TruBridge Swings to Profit on Revenue Growth, Tax Benefit

TL;DR

**TBRG is finally turning the corner, with strong operating cash flow and a swing to profit making it a buy for growth-oriented investors.**

AI Summary

TruBridge, Inc. (TBRG) reported a significant turnaround in its financial performance for the three and nine months ended September 30, 2025. For the three-month period, total revenues increased to $86.106 million from $84.700 million in the prior year, a 1.66% rise. Net income dramatically improved to $5.602 million, or $0.37 per diluted share, compared to a net loss of $9.148 million, or $(0.61) per diluted share, in the same period of 2024. This positive shift was driven by a substantial income tax benefit of $4.250 million, contrasting with a $7.553 million provision in 2024. For the nine-month period, total revenues grew to $259.043 million from $254.416 million, a 1.82% increase. Net income reached $8.641 million, or $0.58 per diluted share, a significant improvement from a net loss of $15.390 million, or $(1.04) per diluted share, in the prior year. The company also saw a reduction in interest expense by $1.030 million for the quarter and $2.898 million for the nine months. Cash and cash equivalents increased to $19.920 million as of September 30, 2025, up from $12.324 million at December 31, 2024, primarily due to $28.107 million in net cash provided by operating activities.

Why It Matters

TruBridge's return to profitability and increased cash flow from operations signal improved financial health, which is crucial for investor confidence and potential future growth initiatives. The company's strategic realignment of its reporting segments to 'Financial Health' and 'Patient Care' aims to enhance operational efficiency and client service, potentially strengthening its competitive position against rivals in the healthcare IT sector. This positive trajectory could lead to increased investment in product development and market expansion, benefiting employees through job security and customers through enhanced service offerings. The reduction in interest expense also indicates better debt management, freeing up capital for other strategic uses.

Risk Assessment

Risk Level: medium — While TruBridge reported a net income, a significant portion of this was due to a $4.250 million income tax benefit for the three months ended September 30, 2025, rather than solely operational improvements. Additionally, the company revised previously issued financial statements for 2024 due to improperly recognized revenue, indicating potential internal control weaknesses that could impact future financial reporting reliability.

Analyst Insight

Investors should consider initiating a position in TBRG, given the strong operational cash flow of $28.107 million and the significant swing to net income. However, closely monitor future filings for sustained profitability driven by core operations, rather than one-time tax benefits, and assess the effectiveness of internal controls following the revenue recognition revision.

Financial Highlights

debt To Equity

1.21

revenue

$86.106M

operating Margin

49.17%

total Assets

$399.412M

total Debt

$164.343M

net Income

$5.602M

eps

$0.37

gross Margin

50.83%

cash Position

$19.920M

revenue Growth

+1.66%

Revenue Breakdown

Key Numbers

• $86.106M — Total Revenues (Q3 2025) (Increased from $84.700M in Q3 2024, a 1.66% rise.)
• $5.602M — Net Income (Q3 2025) (Swing from a net loss of $9.148M in Q3 2024.)
• $0.37 — Diluted EPS (Q3 2025) (Improved from $(0.61) in Q3 2024.)
• $259.043M — Total Revenues (YTD Q3 2025) (Increased from $254.416M in YTD Q3 2024, a 1.82% rise.)
• $8.641M — Net Income (YTD Q3 2025) (Swing from a net loss of $15.390M in YTD Q3 2024.)
• $0.58 — Diluted EPS (YTD Q3 2025) (Improved from $(1.04) in YTD Q3 2024.)
• $19.920M — Cash and Cash Equivalents (Increased from $12.324M at December 31, 2024.)
• $28.107M — Net Cash from Operating Activities (YTD Q3 2025) (Increased from $21.839M in YTD Q3 2024.)
• $4.250M — Income Tax Benefit (Q3 2025) (Contrasts with a $7.553M provision in Q3 2024, significantly impacting net income.)
• $1.030M — Interest Expense Reduction (Q3 2025) (Reduced from $4.033M in Q3 2024 to $3.003M in Q3 2025.)

Key Players & Entities

• TruBridge, Inc. (company) — Registrant for 10-Q filing
• SEC (regulator) — Securities and Exchange Commission
• NASDAQ Stock Market LLC (company) — Exchange where TBRG is registered
• $86.106 million (dollar_amount) — Total revenues for three months ended September 30, 2025
• $5.602 million (dollar_amount) — Net income for three months ended September 30, 2025
• $0.37 (dollar_amount) — Diluted EPS for three months ended September 30, 2025
• $259.043 million (dollar_amount) — Total revenues for nine months ended September 30, 2025
• $8.641 million (dollar_amount) — Net income for nine months ended September 30, 2025
• $0.58 (dollar_amount) — Diluted EPS for nine months ended September 30, 2025
• $28.107 million (dollar_amount) — Net cash provided by operating activities for nine months ended September 30, 2025

FAQ

Risk Factors

• Intangible Asset and Goodwill Impairment [medium — financial]: The company holds significant intangible assets ($67.563M) and goodwill ($172.573M). Declines in future cash flows or changes in market conditions could lead to impairment charges, negatively impacting net income and equity.
• Software Development Costs [medium — operational]: Significant investment in software development ($44.226M net) is crucial for future growth. Delays or failures in development could hinder competitive positioning and revenue generation.
• Accounts Receivable and Credit Risk [medium — financial]: Accounts receivable total $56.771M, with an allowance for credit losses of $4.911M. A deterioration in customer payment capabilities could lead to higher-than-expected credit losses.
• Debt Obligations [medium — financial]: The company has $161.363M in long-term debt. Rising interest rates or a downturn in financial performance could strain the company's ability to service this debt.
• Healthcare Industry Regulations [high — regulatory]: As a provider of solutions to the healthcare industry, TruBridge is subject to complex and evolving regulations. Non-compliance could result in fines, penalties, and reputational damage.
• Competition [medium — market]: The company operates in a competitive landscape. Failure to innovate or maintain a competitive edge could lead to market share erosion and reduced profitability.

Industry Context

TruBridge operates within the healthcare technology and services sector, providing solutions that aim to improve financial health and patient care for healthcare providers. This industry is characterized by increasing regulatory scrutiny, a growing demand for efficiency and cost-containment, and continuous technological innovation. Companies in this space often face pressure to demonstrate clear ROI and compliance with healthcare-specific data privacy and security standards.

Regulatory Implications

As a service provider to the healthcare industry, TruBridge must adhere to stringent regulations such as HIPAA for data privacy and security. Changes in healthcare policy or enforcement actions related to compliance could significantly impact operations and financial performance. The company's substantial income tax benefit in the current quarter highlights the sensitivity of its net income to tax regulations and accounting treatments.

What Investors Should Do

1. Monitor the sustainability of the net income improvement beyond the tax benefit: Analyze the drivers of operational profitability in future quarters to assess if the turnaround is sustainable.
2. Evaluate the growth trajectory of the Patient Care segment: Given its positive growth, assess its potential to offset any stagnation in the Financial Health segment.
3. Assess the impact of intangible asset and goodwill on future performance: Understand the company's strategy for leveraging these assets and monitor for any signs of impairment.
4. Scrutinize the management of accounts receivable and credit losses: Given the significant receivable balance, monitor trends in credit losses for potential financial strain.

Key Dates

• 2025-09-30: End of Q3 2025 — Reported significant net income improvement and increased cash position.
• 2025-12-31: End of Fiscal Year 2024 — Previous period's cash and cash equivalents were $12.324M.
• 2024-09-30: End of Q3 2024 — Reported a net loss of $9.148M and a provision for income taxes of $7.553M.

Glossary

Allowance for credit losses

An estimate of the amount of accounts receivable that the company expects will not be collected. (Indicates the company's assessment of potential bad debts from its customers, impacting reported revenue and net income.)

Accumulated deficit

The total cumulative net losses of a company since its inception, less any cumulative net income. (A negative accumulated deficit indicates the company has historically incurred more losses than profits, though the current period shows improvement.)

Operating lease right-of-use assets

Assets recognized under accounting standards for leases, representing the right to use an asset for the lease term. (Reflects the company's long-term rental commitments for property and equipment.)

Goodwill

An intangible asset that arises when a company acquires another company for a price greater than the fair value of its net identifiable assets. (Represents a significant portion of the company's assets ($172.573M), subject to impairment testing.)

Deferred revenue

Revenue that has been received by the company but not yet earned, as the goods or services have not been delivered or performed. (Represents future revenue obligations, impacting cash flow and future revenue recognition.)

Provision for income taxes

The amount of income tax expense recognized by a company during a period. (A significant factor in net income; a benefit in the current period dramatically improved profitability compared to a provision in the prior year.)

Year-Over-Year Comparison

Compared to the prior year's comparable periods, TruBridge has demonstrated a notable financial recovery. Total revenues saw modest growth of 1.66% for the quarter and 1.82% year-to-date. The most significant improvement is in net income, swinging from substantial losses in 2024 to profits in 2025, largely driven by a substantial income tax benefit and reduced interest expense. Cash and cash equivalents have also seen a healthy increase, supported by strong operating cash flows, indicating improved liquidity and financial stability.

Filing Documents

• tbrg-20250930.htm (10-Q) — 1504KB
• tbrgex10109302025.htm (EX-10.1) — 187KB
• tbrgex31109302025.htm (EX-31.1) — 10KB
• tbrgex31209302025.htm (EX-31.2) — 10KB
• tbrgex32109302025.htm (EX-32.1) — 5KB
• 0001169445-25-000077.txt ( ) — 8751KB
• tbrg-20250930.xsd (EX-101.SCH) — 56KB
• tbrg-20250930_cal.xml (EX-101.CAL) — 102KB
• tbrg-20250930_def.xml (EX-101.DEF) — 245KB
• tbrg-20250930_lab.xml (EX-101.LAB) — 659KB
• tbrg-20250930_pre.xml (EX-101.PRE) — 496KB
• tbrg-20250930_htm.xml (XML) — 1399KB

FINANCIAL INFORMATION

PART I. FINANCIAL INFORMATION

Financial Statements

Item 1. Financial Statements 3 Condensed Consolidated Balance Sheets (Unaudited) – September 30, 2025 and December 31, 2024 3 Condensed Consolidated Statements of Operations (Unaudited) – Three and Nine Months Ended September 30, 2025 and 2024 4 Condensed Consolidated Statements of Comprehensive Income (Loss) (Unaudited) - Three and Nine Months Ended September 30, 2025 and 2024 5 Condensed Consolidated Statements of Stockholders' Equity (Unaudited) – Three and Nine Months Ended September 30, 2025 and 2024 6 Condensed Consolidated Statements of Cash Flows (Unaudited) – Nine Months Ended September 30, 2025 and 2024 7 Notes to Condensed Consolidated Financial Statements (Unaudited) 8

Management's Discussion and Analysis of Financial Condition and Results of Operations

Item 2. Management's Discussion and Analysis of Financial Condition and Results of Operations 30

Quantitative and Qualitative Disclosures about Market Risk

Item 3. Quantitative and Qualitative Disclosures about Market Risk 43

Controls and Procedures

Item 4. Controls and Procedures 44

OTHER INFORMATION

PART II. OTHER INFORMATION

Legal Proceedings

Item 1. Legal Proceedings 46

Risk Factors

Item 1A. Risk Factors 46

Unregistered Sales of Equity Securities and Use of Proceeds

Item 2. Unregistered Sales of Equity Securities and Use of Proceeds 48

Defaults Upon Senior Securities

Item 3. Defaults Upon Senior Securities 48

Mine Safety Disclosures

Item 4. Mine Safety Disclosures 48

Other Information

Item 5. Other Information 48

Exhibits

Item 6. Exhibits 50 2 PART I FINANCIAL INFORMATION Item 1.

Financial Statements

Financial Statements. TRUBRIDGE, INC. CONDENSED CONSOLIDATED BALANCE SHEETS (In thousands, except per share data) (Unaudited) September 30, 2025 December 31, 2024 Assets Current assets: Cash and cash equivalents $ 19,920 $ 12,324 Accounts receivable, net of allowance for credit losses of $ 4,911 and $ 5,861 56,771 53,753 Current portion of financing receivables, net of allowance for credit losses of $ 565 and $ 417 2,961 4,663 Inventories 351 767 Prepaid income taxes 8,602 2,886 Prepaid expenses and other current assets 13,521 15,275 Assets held for sale 445 606 Total current assets 102,571 90,274 Property and equipment, net 2,204 2,294 Software development costs, net 44,226 41,474 Operating lease right-of-use assets 2,391 3,092 Financing receivables, less current portion, net of allowance for credit losses of $ 233 and $ 21 64 232 Other assets, less current portion 7,820 7,786 Intangible assets, net 67,563 76,707 Goodwill 172,573 172,573 Total assets $ 399,412 $ 394,432 Liabilities and Stockholders' Equity Current liabilities: Accounts payable $ 20,238 $ 15,040 Current portion of long-term debt 2,980 2,980 Deferred revenue 8,197 10,653 Accrued vacation 5,091 4,770 Income taxes payable 798 3,538 Other accrued liabilities 16,445 15,994 Total current liabilities 53,749 52,975 Long-term debt, less current portion 161,363 168,598 Operating lease liabilities, less current portion 1,588 2,293 Deferred tax liabilities 2,354 1,871 Total liabilities 219,054 225,737 Commitments and contingencies ( Note 15 ) Stockholders' equity: Common stock, $ 0.001 par value; 30,000 shares authorized; 15,690 shares issued at September 30, 2025 and 15,522 shares issued at December 31, 2024 15 15 Additional paid-in capital 206,164 201,066 Accumulated deficit ( 6,311 ) ( 14,952 ) Accumulated other comprehensive (loss) income ( 91 ) 45 Treasury stock, 689 shares at September 30, 2025 and 619 shares at December 31, 2024 ( 19,419 ) ( 17,479 )

View Full Filing

View this 10-Q filing on SEC EDGAR